We're hugely excited to announce that ThinkSono's AI Training Software (iOS) is now officially available to all Butterfly Network, Inc. iQ Users via the Apple App Store! This means that if you wish to learn how to perform a DVT Ultrasound scan, you can download it on your iPhone/iPad and get real-time guidance!* Our iOS App is both available in the Butterfly Garden, ThinkSono website or directly via the Apple App Store! If you have an iPhone you can download it and try it out! Thanks to the entire team at Butterfly for making this happen! Official Links below: Press release: https://lnkd.in/eZd9WQd7 Butterfly Garden: https://lnkd.in/ekFF4ZpJ ThinkSono Website: https://lnkd.in/edW_uBeB Apple Store Link: https://lnkd.in/eyWQwzpX *Compatible Butterfly iQ Device required. Please see press release for more information. Note: ThinkSono AI Training is for training purposes only and not used for diagnosis or any clinical decision making. It is not FDA or CE marked as it is not a medical device. ThinkSono AI Training is only available on iOS with Butterfly Devices. Calvin Solomon, Samhita Gaddam, Darius Shahida, Joe DeVivo, Liz Learned Snyder, Anand Shah, Sven Mischkewitz, Sören Tietböhl
ThinkSono
Software Development
Building the future of ultrasound with artificial intelligence.
About us
At ThinkSono, we are committed to removing the barriers to universal ultrasound access. We are working towards a world where ultrasound diagnosis can be provided safely at the point of care by any healthcare professional. Our first application ThinkSono Guidance enables any healthcare professional to detect deep vein thrombosis (DVT) at the point of care in as little as 5 minutes. It uses artificial intelligence to guide the user through the current gold-standard diagnosis, a compression ultrasound examination.
- Website
-
http://thinksono.com
External link for ThinkSono
- Industry
- Software Development
- Company size
- 2-10 employees
- Headquarters
- London
- Type
- Privately Held
- Founded
- 2016
Locations
-
Primary
London, GB
Employees at ThinkSono
-
Michael Blaivas, MD, MBA, FACEP, FAIUM
Chief Medical Officer, ThinkSono. Chief Medical Officer, AutonomUS Medical Tech. Fractional CMO Leadership. Machine Learning Innovator in…
-
Fouad Al-Noor
Co-founder & CEO at ThinkSono
-
Nam Nhito
VC Investor - Life Sciences & Health
-
Sven Mischkewitz
Co-founder at ThinkSono
Updates
-
We're very excited that our CEO Fouad Al-Noor has been invited to 10 Downing Street to discuss how to best use AI in Healthcare and support the NHS in adopting AI in clinical practice!
I'm pleased to have been invited to 10 Downing Street at the AI Round Table to represent ThinkSono and discuss how best to support the UK in implementing AI. Thank you for setting this whole thing up Startup Coalition and Matt Clifford. The UK has a huge opportunity to lead in the AI revolution, and in particular when it comes to AI in healthcare. Seeing the proactive approach by the new Government is very exciting and gives us a boost to ensure that the NHS truly benefits from AI. More info found here: https://lnkd.in/gsy9_nXp CC Peter Kyle
-
-
ThinkSono reposted this
Here at the PCA we’re excited to announce a new partnership with ThinkSono. Working together we’ve created a unique deep vein thrombosis (DVT) training and certification package that pairs ThinkSono’s AI training with POCUS certification. You too can learn to identify DVT. Check out the package 👉 https://bit.ly/3xJFdeb #POCUS
-
-
We're excited to partner with Inteleos and Point-of-Care Ultrasound Certification Academy to improve point of care ultrasound training for all healthcare staff! Read the press release for more information!
More good news coming out of Inteleos' Point-of-Care Ultrasound Certification Academy! PCA and ThinkSono have partnered to enhance healthcare professionals' skills in detecting Deep Vein Thrombosis (DVT) using #POCUS. This partnership aims to improve patient outcomes by streamlining the proficient use of POCUS making ultrasound more accessible to healthcare professionals worldwide! Read the release to learn more about this amazing collaboration! 🎉 Congratulations, team! Here's to #innovation in #education!
-
Listen to our CMO Michael Blaivas, MD, MBA, FACEP, FAIUM talking about AI in Ultrasound!
“As we have more data, [clinicians] become more comfortable with [AI], and regulatory agencies become more comfortable with it. This will turn into a true manifestation of the AI capability, which is like having a professor or expert standing over your shoulder.” In this week's episode of #TheScoopOnUltrasound, we're joined by Michael Blaivas, MD, MBA, FACEP, FAIUM, Chief Medical Officer of ThinkSono. Dr. Blaivas walks us through AI's transformative impact on ultrasound imaging. He highlights how AI improves workflow, automates complex calculations, and reduces variability in radiology and cardiology. With over 25 years of experience, Dr. Blaivas has been key in developing point-of-care COVID-19 diagnostics and AI-based imaging devices. A pioneer in point-of-care ultrasound, he has published 250 peer-reviewed articles and edited six medical textbooks. His research focus for the past eight years has been on AI applications. For over five years, Dr. Blaivas served as the Deputy Editor of the Journal of Ultrasound in Medicine. He also served two terms as Third Vice President of the American Institute of Ultrasound in Medicine (AIUM). Dr. Blaivas envisions AI-driven guidance making advanced imaging accessible and reliable. Don't miss this insightful interview to learn how these innovations could shape the future of ultrasound and healthcare as we know it! #AI #Ultrasound #Healthcare #MedicalImaging #ArtificialIntelligence
S2 E3: AI in Action – Insights from ThinkSono’s Chief Medical Officer
EDM Medical Solutions on LinkedIn
-
We're pleased to announce that another ThinkSono prospective clinical study led by Kerstin Nothnagel has been published in BJGP Open! Have a look at the post below for the details!
I'm pleased to say that another ThinkSono prospective clinical study led by Kerstin Nothnagel has been published in BJGP Open! The results are hugely positive, with the study results and conclusion stating: Results Among 91 predominantly elderly female participants, 18% of scans were incomplete. Of the rest, 91% had sufficient quality, with 64% categorised by remote clinicians as "compressible" or "incompressible." Sensitivity and specificity for adequately imaged scans were 100% and 91%, respectively. Notably, 53% were low risk, potentially obviating formal scans. Conclusion ThinkSono Guidance effectively directed non-specialists, streamlining DVT diagnosis and treatment. It may reduce the need for formal scans, particularly with negative findings, and extend diagnostic capabilities to primary care. The study highlights AI-assisted POCUS potential in improving DVT assessment. ThinkSono is now the leader in Ultrasound AI for DVT. We will keep publishing all clinical study results (whether they are positive or not) and continue our work to transform the care for all DVT patients. Thanks to all patients and staff who participated and of course thanks to Kerstin Nothnagel for the huge amount of work done. As a note, she's also running another 500 patients study in Bristol together with GP CARE UK LIMITED and University of Bristol (link below) and we'll publish the results of that study once its publicly available. BJGP study: https://lnkd.in/ePXnt2Ku Bristol study: https://lnkd.in/ecqtEq3K
Evaluating the benefits of machine learning for diagnosing deep vein thrombosis compared to gold standard ultrasound- a feasibility study
bjgpopen.org
-
We’re #hiring! If you are a sales executive and interested in having a massive impact on the lives of DVT patients, then apply to this position at ThinkSono! The person we are looking for should bring the company to the next level. Practically this means supporting us with full commercalisation in the UK/EU. The details are in the job description. Tips for applying to this position: 1. The top candidate will be expected to have reviewed the website, watched company presentations, understood the ThinkSono Guidance product, and has strong understanding of how they would approach the sales process. Their understanding of the DVT and VTE space must be strong (i.e., a deep understanding of the clinical pathway and its limitations) as this would indicate whether they are suitable for the role. 2. We expect the candidate to explain why they specifically want to work with ThinkSono and how their experience can contribute to the success of the company and how they plan to sell the product. 3. We expect the candidate to be transparent about their strengths and limitations to see if the role is a fit, and how the company can help to ensure the candidate is supported in their work. Note: If the application to this role is seen as too generic and does not address this post specifically then it would be unlikely to go through to an interview. Finally, we do not accept agency referrals, so please apply directly. Unfortunately, many people will just apply without carefully reading the job description and we do get a lot of spam. So please try to read it carefully, otherwise we'll just assume it's spam (which we're constantly bombarded with).
-
Thank you for an amazing job Kerstin Nothnagel!
Well done to Kerstin Nothnagel and the whole team at GP CARE UK LIMITED for having recruited nearly 500 patients using ThinkSono technology for DVT detection in primary care. To my knowledge this is the largest ever prospective study for AI Ultrasound to detect DVT. The potential of our ThinkSono Guidance software to improve the management of DVT worldwide is massive! You can read more about the study here: https://lnkd.in/ecqtEq3K
Why is this research important?
aipocus.blogs.bristol.ac.uk
-
ThinkSono reposted this
Congratulations to Samsung Medison and Sonio! Ultrasound AI is the future of medicine. Obviously at ThinkSono we’re heavily involved in this, and from what I can see, the entire industry will be transformed. The reason is simple. Ultrasound is non-invasive, portable, has dynamic real-time images, is used in nearly every medical specialty and is relatively inexpensive. The limitation of ultrasound has fundamentally been the need for specialist to scan patients and interpret the images. With AI, this barrier will be removed and the power of the technology truly unlocked. For those in healthcare, I suggest you watch this space closely. This is just the start.
Samsung Medison buys AI software firm Sonio SAS for $92 mln
reuters.com